| Authors | Sophie Dupuis-Girod |
| Journal | Presse medicale (Paris, France : 1983)
(Presse Med)
Vol. 42
Issue 4 Pt 1
Pg. 385-7
(Apr 2013)
ISSN: 2213-0276 [Electronic] France |
| Vernacular Title | Anti-VEGF: une avancée thérapeutique dans la maladie de Rendu-Osler. |
| PMID | 23428664
(Publication Type: Editorial)
|
| Chemical References |
- Antibodies, Monoclonal, Humanized
- Antigens, CD
- ENG protein, human
- Endoglin
- Receptors, Cell Surface
- SMAD4 protein, human
- Smad4 Protein
- VEGFA protein, human
- Vascular Endothelial Growth Factor A
- Bevacizumab
- ACVRL1 protein, human
- Activin Receptors, Type II
|
| Topics |
- Activin Receptors, Type II
(genetics)
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal, Humanized
(adverse effects, therapeutic use)
- Antigens, CD
(genetics)
- Bevacizumab
- DNA Mutational Analysis
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Endoglin
- Female
- Humans
- Injections, Intravenous
- Male
- Middle Aged
- Prospective Studies
- Receptors, Cell Surface
(genetics)
- Smad4 Protein
(genetics)
- Telangiectasia, Hereditary Hemorrhagic
(diagnosis, drug therapy, genetics)
- Treatment Outcome
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors)
- Young Adult
|
